中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
Chinese Journal of General Surgery
2015年
9期
676-679
,共4页
甲状腺肿瘤%癌,乳头状%甲状腺切除术%颈淋巴结清扫术
甲狀腺腫瘤%癌,乳頭狀%甲狀腺切除術%頸淋巴結清掃術
갑상선종류%암,유두상%갑상선절제술%경림파결청소술
Thyroid neoplasms%Carcinoma,papillary%Thyroidectomy%Neck dissection
目的 探讨经胸乳入路腔镜行甲状腺癌治疗的可行性. 方法 回顾性分析2009年4月至2013年12月90例全腔镜下治疗cN0甲状腺乳头状癌的临床资料.结果 90例无一例中转开放手术,手术时间平均97 min,术中出血量平均10 ml;术后平均引流量65 ml,平均住院日4.5d,清扫中央区淋巴结数目平均5.3个.术后无明显皮肤瘀斑、积液或感染.术后无一例出现低钙抽搐,暂时性声音嘶哑3例,于术后1～2个月恢复正常.所有患者术后均获得随访,随访时间1～5年,中位随访时间41个月,B超等复查均未提示肿瘤复发及中央区淋巴结肿大.患者均对美容效果满意.结论经胸乳入路行腔镜甲状腺癌治疗是安全可行的.
目的 探討經胸乳入路腔鏡行甲狀腺癌治療的可行性. 方法 迴顧性分析2009年4月至2013年12月90例全腔鏡下治療cN0甲狀腺乳頭狀癌的臨床資料.結果 90例無一例中轉開放手術,手術時間平均97 min,術中齣血量平均10 ml;術後平均引流量65 ml,平均住院日4.5d,清掃中央區淋巴結數目平均5.3箇.術後無明顯皮膚瘀斑、積液或感染.術後無一例齣現低鈣抽搐,暫時性聲音嘶啞3例,于術後1～2箇月恢複正常.所有患者術後均穫得隨訪,隨訪時間1～5年,中位隨訪時間41箇月,B超等複查均未提示腫瘤複髮及中央區淋巴結腫大.患者均對美容效果滿意.結論經胸乳入路行腔鏡甲狀腺癌治療是安全可行的.
목적 탐토경흉유입로강경행갑상선암치료적가행성. 방법 회고성분석2009년4월지2013년12월90례전강경하치료cN0갑상선유두상암적림상자료.결과 90례무일례중전개방수술,수술시간평균97 min,술중출혈량평균10 ml;술후평균인류량65 ml,평균주원일4.5d,청소중앙구림파결수목평균5.3개.술후무명현피부어반、적액혹감염.술후무일례출현저개추휵,잠시성성음시아3례,우술후1～2개월회복정상.소유환자술후균획득수방,수방시간1～5년,중위수방시간41개월,B초등복사균미제시종류복발급중앙구림파결종대.환자균대미용효과만의.결론경흉유입로행강경갑상선암치료시안전가행적.
Objective To discuss the feasibility of endoscopic thyroidectomy via breast approach for papillary thyroid carcinoma.Methods From April 2009 to December 2013,clinical data of 90 papillary thyroid carcinoma cases undergoing endoscopic thyroidectomy was analyzed retrospectively.Results There was no conversion to open surgery,the mean operation time was 97 min,the mean intraoperative blood loss was 10 ml,the mean postoperative drainage volume was 65 ml,the mean hospital stay was 4.5 d,the mean lymph node number dissection of central compartment was 5.3.No obviously chest pain and numbness occurred.No skin flap ecchymosis,necrosis,effusion,and hematoma occurred.No hypocalcemia convulsions occurred.Transient hoarseness occurred in 3 cases which recovered within 1 to 2 months.Follow-up time ranged from 1 to 5 years,the median follow-up time was 41 months,with no tumor recurrence and lymph node enlargement.All patients were satisfied with the cosmetic results.Conclusions Endoscopic thyroidectomy via breast approach is a safe and feasible procedure in treating papillary thyroid carcinoma (cN0).
